Publicacions destacades
-
Predictive Factors for HIV Seroconversion Among Individuals Attending a Specialized Center After an HIV Risk Exposure: A Case-Control Study
Autors:Referència: Aids Research And Human Retroviruses 2016. -
PK, Ex-vivo Efficacy on HIV Infectivity and Effect on Immune System of Maraviroc, Raltegravir and Ritonavir-boosted Lopinavir in MSM on PEP
Autors:Referència: Aids Research And Human Retroviruses 2016. -
Tenofovir/Emtricitabine plus Lopinavir/Ritonavir or Elvitegravir/cobicistat as a Single Tablet Regimen (STR) for PEP: A Randomized Clinical Trial
Autors:Referència: Aids Research And Human Retroviruses 2016. -
HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses
Autors:Referència: Journal Of Virology 2015. -
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
Autors:Referència: Journal Of Antimicrobial Chemotherapy 2015. -
Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients
Autors:Referència: Aids 2015. -
Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation
Autors:Referència: Journal Of The International Aids Society 2014. -
Immunological function restoration with Lopinavir/ritonavir vs Efavirenz containing regimens in HIV infected patients: a randomized clinical trial
Autors:Referència: Aids Research And Human Retroviruses 2014. -
Comparison of two HIV testing strategies in primary care centres: condition-guided testing vs. testing of those with non-indicator conditions
Autors:Referència: Hiv Medicine 2013. -
Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm(3)
Autors:Referència: Aids Research And Human Retroviruses 2013.